Recurrent giant cell tumor of the right distal tibia: A case report
- 1Department of Clinical Research, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India
- 2Department of Pathology, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India
Abstract
Giant cell tumors (GCTs) of the bone are neoplasms that are characterized by benign, locally aggressive behavior and occur most commonly in the young population. It is usually located at epiphyseal areas of bones, especially distal femur and proximal tibia. This paper presents a 20-year-old female, who presented with a malignant recurrence of GCT in the right distal tibia which had initially been treated by curettage with cement and bone grafting. The patient managed in August 2021 and came back in 2023 with the symptoms of recurrence manifested by swelling, pain, and functional limitation of the right ankle. Curettage and cement augmentation surgery were accomplished successfully. There were no complications in the postoperative course, and the patient reported symptom improvement and increased functional abilities at follow-up. It discusses the complexities of the management of recurrent GCTs, while stressing the importance of detailed planning of surgeries, intraoperative and postoperative multidisciplinary management, and long-term follow-up. It also addresses modern management styles: Adjuvants and the role of imaging in detecting recurrences. If it is handled well, those challenges can help enhance the end result in patients with recurrent GCTs, especially in sensitive areas such as the distal tibia.
Related
- Campanacci Grade III Giant Cell Tumor of the Distal Femur Treated With Wide En Bloc Resection and Cemented Modular Megaprosthetic Reconstruction: A Case Report
- Giant Cell Tumor of the Distal Phalanx of the Great Toe: Case Report.
- Case Report: Genotype-informed management after clinically necessary cytoreduction for giant recurrent gastric gastrointestinal stromal tumor with prior rupture and KIT exon 17 N822Y mutation
- Outcomes of simultaneous microsurgical replantation of complete amputations at the distal third of the right forearm and left wrist: a case report and 22-month follow-up
- Multidisciplinary Management of a Giant Ovarian Sertoli–Leydig Cell Tumor Presenting With Isosexual Precocious Puberty: A Pediatric Case Report
BibTeX
@article{barole2026recurrent,
title = {{Recurrent giant cell tumor of the right distal tibia: A case report}},
author = {Nisha D. Barole and Kuntal P. Godde and Vaishnavi D. Rajurkar and Shubhangi P. Raut},
journal = {Journal of family medicine and primary care},
year = {2026},
month = jul,
doi = {10.4103/jfmpc.jfmpc_103_25},
url = {https://europepmc.org/article/PMC/PMC13722257},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Recurrent giant cell tumor of the right distal tibia: A case report
AU - Nisha D. Barole
AU - Kuntal P. Godde
AU - Vaishnavi D. Rajurkar
AU - Shubhangi P. Raut
PY - 2026
DA - 2026/07/01
JO - Journal of family medicine and primary care
DO - 10.4103/jfmpc.jfmpc_103_25
UR - https://europepmc.org/article/PMC/PMC13722257
AB - Giant cell tumors (GCTs) of the bone are neoplasms that are characterized by benign, locally aggressive behavior and occur most commonly in the young population. It is usually located at epiphyseal areas of bones, especially distal femur and proximal tibia. This paper presents a 20-year-old female, who presented with a malignant recurrence of GCT in the right distal tibia which had initially been treated by curettage with cement and bone grafting. The patient managed in August 2021 and came back in 2023 with the symptoms of recurrence manifested by swelling, pain, and functional limitation of the right ankle. Curettage and cement augmentation surgery were accomplished successfully. There were no complications in the postoperative course, and the patient reported symptom improvement and increased functional abilities at follow-up. It discusses the complexities of the management of recurrent GCTs, while stressing the importance of detailed planning of surgeries, intraoperative and postoperative multidisciplinary management, and long-term follow-up. It also addresses modern management styles: Adjuvants and the role of imaging in detecting recurrences. If it is handled well, those challenges can help enhance the end result in patients with recurrent GCTs, especially in sensitive areas such as the distal tibia.
SN - 2249-4863
SN - 2278-7135
ER -